Rank | Gene Set | Z-score |
---|---|---|
1 | proteasome assembly (GO:0043248) | 4.76286894 |
2 | membrane raft organization (GO:0031579) | 4.49025611 |
3 | regulation of metalloenzyme activity (GO:0048552) | 4.46566072 |
4 | ribosomal small subunit assembly (GO:0000028) | 4.41586729 |
5 | COPI coating of Golgi vesicle (GO:0048205) | 4.35244293 |
6 | Golgi transport vesicle coating (GO:0048200) | 4.35244293 |
7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.22925001 |
8 | sequestering of actin monomers (GO:0042989) | 4.02685012 |
9 | ATP synthesis coupled proton transport (GO:0015986) | 3.94741785 |
10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.94741785 |
11 | protein maturation by protein folding (GO:0022417) | 3.80306674 |
12 | membrane budding (GO:0006900) | 3.77685853 |
13 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.75236670 |
14 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.66947148 |
15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.61279544 |
16 | phagosome maturation (GO:0090382) | 3.59155179 |
17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.53060434 |
18 | protein complex biogenesis (GO:0070271) | 3.48626462 |
19 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.46801247 |
20 | negative regulation of ligase activity (GO:0051352) | 3.46801247 |
21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.43054303 |
22 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.40675392 |
23 | positive regulation of actin filament depolymerization (GO:0030836) | 3.40507126 |
24 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.37098146 |
25 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.37098146 |
26 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.35096730 |
27 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.34620542 |
28 | transferrin transport (GO:0033572) | 3.32540756 |
29 | chaperone-mediated protein transport (GO:0072321) | 3.26058181 |
30 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.25936611 |
31 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.23126548 |
32 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.23126548 |
33 | intestinal epithelial cell development (GO:0060576) | 3.19836668 |
34 | desmosome organization (GO:0002934) | 3.17929581 |
35 | respiratory electron transport chain (GO:0022904) | 3.14744531 |
36 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.14344312 |
37 | NADH dehydrogenase complex assembly (GO:0010257) | 3.14344312 |
38 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.14344312 |
39 | hepatocyte apoptotic process (GO:0097284) | 3.14035770 |
40 | regulation of cellular amine metabolic process (GO:0033238) | 3.13775270 |
41 | mast cell activation (GO:0045576) | 3.11730067 |
42 | response to interferon-beta (GO:0035456) | 3.11643719 |
43 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.11218474 |
44 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.10647911 |
45 | electron transport chain (GO:0022900) | 3.09806298 |
46 | protein heterotetramerization (GO:0051290) | 3.09310545 |
47 | viral transcription (GO:0019083) | 3.07194553 |
48 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.04615998 |
49 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.04494722 |
50 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.04317041 |
51 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.04090423 |
52 | dopamine transport (GO:0015872) | 3.00854825 |
53 | ferric iron transport (GO:0015682) | 2.99783326 |
54 | trivalent inorganic cation transport (GO:0072512) | 2.99783326 |
55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.95031343 |
56 | positive regulation of ligase activity (GO:0051351) | 2.94874254 |
57 | cytochrome complex assembly (GO:0017004) | 2.93565203 |
58 | response to protozoan (GO:0001562) | 2.92513989 |
59 | cell adhesion mediated by integrin (GO:0033627) | 2.91823468 |
60 | GDP-mannose metabolic process (GO:0019673) | 2.90018729 |
61 | ribosomal small subunit biogenesis (GO:0042274) | 2.89364347 |
62 | translational termination (GO:0006415) | 2.89317748 |
63 | platelet dense granule organization (GO:0060155) | 2.87965520 |
64 | DNA deamination (GO:0045006) | 2.87377652 |
65 | synaptic vesicle exocytosis (GO:0016079) | 2.86907909 |
66 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84871805 |
67 | leukocyte aggregation (GO:0070486) | 2.84007713 |
68 | respiratory burst (GO:0045730) | 2.83785027 |
69 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.82550074 |
70 | respiratory chain complex IV assembly (GO:0008535) | 2.80612011 |
71 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.79528931 |
72 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.78954113 |
73 | catecholamine transport (GO:0051937) | 2.78531017 |
74 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.78147378 |
75 | COPII vesicle coating (GO:0048208) | 2.75835117 |
76 | defense response to protozoan (GO:0042832) | 2.75803879 |
77 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.75555950 |
78 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75555950 |
79 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.75433562 |
80 | cotranslational protein targeting to membrane (GO:0006613) | 2.75165563 |
81 | skin morphogenesis (GO:0043589) | 2.74326251 |
82 | positive regulation of cell cycle arrest (GO:0071158) | 2.74104175 |
83 | neutrophil activation involved in immune response (GO:0002283) | 2.73549649 |
84 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.73268589 |
85 | protein neddylation (GO:0045116) | 2.72811556 |
86 | protein targeting to ER (GO:0045047) | 2.67940447 |
87 | interferon-gamma production (GO:0032609) | 2.67922776 |
88 | actin filament depolymerization (GO:0030042) | 2.67075308 |
89 | negative regulation of phagocytosis (GO:0050765) | 2.66342545 |
90 | xenobiotic catabolic process (GO:0042178) | 2.65546196 |
91 | positive regulation of protein homodimerization activity (GO:0090073) | 2.65496927 |
92 | mast cell degranulation (GO:0043303) | 2.64926555 |
93 | mast cell activation involved in immune response (GO:0002279) | 2.64926555 |
94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.62248820 |
95 | cellular response to interferon-beta (GO:0035458) | 2.61389746 |
96 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.61283766 |
97 | protein localization to endoplasmic reticulum (GO:0070972) | 2.60812503 |
98 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.60371461 |
99 | cellular response to interleukin-15 (GO:0071350) | 2.58577177 |
100 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.55966106 |
101 | viral life cycle (GO:0019058) | 2.54946002 |
102 | hydrogen ion transmembrane transport (GO:1902600) | 2.54625842 |
103 | ribosome assembly (GO:0042255) | 2.54101993 |
104 | cellular protein complex disassembly (GO:0043624) | 2.52673876 |
105 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.52016362 |
106 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.51832117 |
107 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.49535012 |
108 | cellular response to zinc ion (GO:0071294) | 2.49266713 |
109 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.48962671 |
110 | translational elongation (GO:0006414) | 2.48896367 |
111 | negative regulation of protein ubiquitination (GO:0031397) | 2.48260525 |
112 | viral protein processing (GO:0019082) | 2.47694345 |
113 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.47660959 |
114 | NADH metabolic process (GO:0006734) | 2.46600199 |
115 | regulation of ligase activity (GO:0051340) | 2.46111093 |
116 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.43552943 |
117 | negative regulation of cell killing (GO:0031342) | 2.43552943 |
118 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.43539102 |
119 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.43531470 |
120 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.42123322 |
121 | leukocyte degranulation (GO:0043299) | 2.41852496 |
122 | L-fucose catabolic process (GO:0042355) | 2.41052742 |
123 | fucose catabolic process (GO:0019317) | 2.41052742 |
124 | L-fucose metabolic process (GO:0042354) | 2.41052742 |
125 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.40843618 |
126 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.40843618 |
127 | glutathione derivative biosynthetic process (GO:1901687) | 2.39896869 |
128 | glutathione derivative metabolic process (GO:1901685) | 2.39896869 |
129 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.39800859 |
130 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.39337411 |
131 | L-phenylalanine metabolic process (GO:0006558) | 2.39337411 |
132 | positive regulation of lamellipodium assembly (GO:0010592) | 2.38881649 |
133 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.38647096 |
134 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.37887925 |
135 | diterpenoid biosynthetic process (GO:0016102) | 2.37668625 |
136 | proton transport (GO:0015992) | 2.36675389 |
137 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.36081214 |
138 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.35685811 |
139 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.35392322 |
140 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.34480484 |
141 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.34204718 |
142 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.33447866 |
143 | histamine secretion (GO:0001821) | 2.32865469 |
144 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.32844153 |
145 | vocalization behavior (GO:0071625) | 2.32525503 |
146 | cullin deneddylation (GO:0010388) | 2.32448497 |
147 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.32349056 |
148 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.32014960 |
149 | actin nucleation (GO:0045010) | 2.30653524 |
150 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.30566702 |
151 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.30566702 |
152 | negative regulation of type 2 immune response (GO:0002829) | 2.30434917 |
153 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.29911153 |
154 | hydrogen transport (GO:0006818) | 2.29702749 |
155 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.28984386 |
156 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.28708651 |
157 | response to interleukin-15 (GO:0070672) | 2.28591255 |
158 | protein deneddylation (GO:0000338) | 2.28506816 |
159 | regulation of respiratory burst (GO:0060263) | 2.28485184 |
160 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.27577030 |
161 | oxidative phosphorylation (GO:0006119) | 2.27407471 |
162 | type B pancreatic cell proliferation (GO:0044342) | 2.27354821 |
163 | barbed-end actin filament capping (GO:0051016) | 2.27158425 |
164 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.27019331 |
165 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.26850800 |
166 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.26850800 |
167 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.26850800 |
168 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.26388345 |
169 | cell redox homeostasis (GO:0045454) | 2.25881039 |
170 | regulation of interleukin-8 secretion (GO:2000482) | 2.25135792 |
171 | regulation of water loss via skin (GO:0033561) | 2.24506157 |
172 | regulation of substrate adhesion-dependent cell spreading (GO:1900024) | 2.24335873 |
173 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.20796750 |
174 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.20796750 |
175 | protein retention in ER lumen (GO:0006621) | 2.20605680 |
176 | positive regulation of pseudopodium assembly (GO:0031274) | 2.19158652 |
177 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.17518515 |
178 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.17219504 |
179 | regulation of cell cycle arrest (GO:0071156) | 2.14806213 |
180 | signal transduction in response to DNA damage (GO:0042770) | 2.13753534 |
181 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.13581636 |
182 | cellular response to interferon-alpha (GO:0035457) | 2.13577931 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.39579362 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.78957149 |
3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.76113168 |
4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.61115436 |
5 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.56436768 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.54014008 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.37026790 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.20037643 |
9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.15384485 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.07404639 |
11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03544552 |
12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.99052754 |
13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.95260341 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.94284088 |
15 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.87080567 |
16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.86053908 |
17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71578938 |
18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.61709645 |
19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.55866159 |
20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.51362695 |
21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.51296353 |
22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.46685268 |
23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.46227953 |
24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39382315 |
25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.35436807 |
26 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.29809347 |
27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.27699935 |
28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.25656120 |
29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.25196333 |
30 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18024417 |
31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.16192515 |
32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.14476203 |
33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.11884362 |
34 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.08722626 |
35 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.08722626 |
36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.08614677 |
37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08482147 |
38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.07301683 |
39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.04464776 |
40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.02726405 |
41 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.93747197 |
42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.93163530 |
43 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.91089128 |
44 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.87584619 |
45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86257726 |
46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.85196589 |
47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.83473832 |
48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80886946 |
49 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.79941349 |
50 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.78652365 |
51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78117411 |
52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.76712393 |
53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.76630031 |
54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74876772 |
55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.73535811 |
56 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.73261134 |
57 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.71923792 |
58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.71648291 |
59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69569011 |
60 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.69428181 |
61 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.68268783 |
62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67917438 |
63 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.64616089 |
64 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.64169536 |
65 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.62335655 |
66 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.61299709 |
67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57742367 |
68 | MYB_26560356_Chip-Seq_TH2_Human | 1.55872447 |
69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.55612720 |
70 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54490275 |
71 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.53611470 |
72 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.52659148 |
73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.51639052 |
74 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.49185308 |
75 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48524464 |
76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47737687 |
77 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42838086 |
78 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.41457530 |
79 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.41087864 |
80 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.40725720 |
81 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.40619427 |
82 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40617061 |
83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38759738 |
84 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38409481 |
85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38135263 |
86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.37075979 |
87 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.37036167 |
88 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.35871402 |
89 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35227691 |
90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.34606799 |
91 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.32838870 |
92 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30518828 |
93 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.30316008 |
94 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.29056323 |
95 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28489909 |
96 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.28441048 |
97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28049125 |
98 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.27962653 |
99 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27900020 |
100 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.26675702 |
101 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.26449696 |
102 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.26206732 |
103 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25650817 |
104 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.25118513 |
105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24921468 |
106 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.24591199 |
107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.22562281 |
108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22257271 |
109 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.20387461 |
110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19983391 |
111 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19598715 |
112 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19006924 |
113 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18991530 |
114 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.18696075 |
115 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18098640 |
116 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.17596945 |
117 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16981515 |
118 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.15774721 |
119 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.15222599 |
120 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13674252 |
121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11148836 |
122 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10197973 |
123 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09682249 |
124 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08588977 |
125 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08182954 |
126 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.07908244 |
127 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06979366 |
128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06501478 |
129 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06162747 |
130 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05473095 |
131 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.04826407 |
132 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.03564852 |
133 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.03458561 |
134 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03393874 |
135 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.03374744 |
136 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02678273 |
137 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.01816703 |
138 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.01694273 |
139 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01406940 |
140 | VDR_22108803_ChIP-Seq_LS180_Human | 1.01035866 |
141 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00208572 |
142 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99375285 |
143 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.99151623 |
144 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98087552 |
145 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97599724 |
146 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.96802275 |
147 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95113463 |
148 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94791651 |
149 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94246250 |
150 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94151215 |
151 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.93332996 |
152 | MAF_26560356_Chip-Seq_TH1_Human | 0.92855150 |
153 | MYB_26560356_Chip-Seq_TH1_Human | 0.92645140 |
154 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90342078 |
155 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90290750 |
156 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90012150 |
157 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89634122 |
158 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.89506593 |
159 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88773819 |
160 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88676017 |
161 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.87481226 |
162 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87042643 |
163 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.86638820 |
164 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85554968 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003806_abnormal_nucleotide_metabolis | 4.22450692 |
2 | MP0003880_abnormal_central_pattern | 3.52112472 |
3 | MP0001835_abnormal_antigen_presentation | 3.31769854 |
4 | MP0003950_abnormal_plasma_membrane | 3.09367617 |
5 | MP0009785_altered_susceptibility_to | 3.02005864 |
6 | MP0010234_abnormal_vibrissa_follicle | 3.00278238 |
7 | MP0003724_increased_susceptibility_to | 2.93176098 |
8 | MP0005671_abnormal_response_to | 2.92624334 |
9 | MP0003191_abnormal_cellular_cholesterol | 2.86462036 |
10 | MP0005360_urolithiasis | 2.51869044 |
11 | MP0009379_abnormal_foot_pigmentation | 2.48666526 |
12 | MP0008438_abnormal_cutaneous_collagen | 2.48162108 |
13 | MP0002148_abnormal_hypersensitivity_rea | 2.45076209 |
14 | MP0001968_abnormal_touch/_nociception | 2.36482013 |
15 | MP0002736_abnormal_nociception_after | 2.35459334 |
16 | MP0009780_abnormal_chondrocyte_physiolo | 2.27447897 |
17 | MP0002796_impaired_skin_barrier | 2.23587972 |
18 | MP0003566_abnormal_cell_adhesion | 2.21012502 |
19 | MP0005025_abnormal_response_to | 2.16793025 |
20 | MP0009840_abnormal_foam_cell | 2.15098703 |
21 | MP0002735_abnormal_chemical_nociception | 2.14595121 |
22 | MP0004272_abnormal_basement_membrane | 2.12935515 |
23 | MP0003866_abnormal_defecation | 2.11521778 |
24 | MP0003186_abnormal_redox_activity | 2.09833548 |
25 | MP0006054_spinal_hemorrhage | 2.09182991 |
26 | MP0005000_abnormal_immune_tolerance | 2.08193343 |
27 | MP0003941_abnormal_skin_development | 2.04028095 |
28 | MP0003763_abnormal_thymus_physiology | 1.97774889 |
29 | MP0002420_abnormal_adaptive_immunity | 1.96998599 |
30 | MP0001188_hyperpigmentation | 1.96291160 |
31 | MP0001819_abnormal_immune_cell | 1.95908100 |
32 | MP0000685_abnormal_immune_system | 1.95313654 |
33 | MP0002877_abnormal_melanocyte_morpholog | 1.91433378 |
34 | MP0001905_abnormal_dopamine_level | 1.91026416 |
35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.89912560 |
36 | MP0001986_abnormal_taste_sensitivity | 1.88293673 |
37 | MP0002419_abnormal_innate_immunity | 1.85493970 |
38 | MP0001873_stomach_inflammation | 1.83433039 |
39 | MP0002139_abnormal_hepatobiliary_system | 1.82334343 |
40 | MP0002723_abnormal_immune_serum | 1.81546548 |
41 | MP0009745_abnormal_behavioral_response | 1.81007082 |
42 | MP0003183_abnormal_peptide_metabolism | 1.80631870 |
43 | MP0002452_abnormal_antigen_presenting | 1.79479335 |
44 | MP0001800_abnormal_humoral_immune | 1.79273557 |
45 | MP0005387_immune_system_phenotype | 1.78260625 |
46 | MP0001790_abnormal_immune_system | 1.78260625 |
47 | MP0005408_hypopigmentation | 1.77178886 |
48 | MP0003635_abnormal_synaptic_transmissio | 1.74454752 |
49 | MP0005023_abnormal_wound_healing | 1.74372108 |
50 | MP0004859_abnormal_synaptic_plasticity | 1.70717939 |
51 | MP0003436_decreased_susceptibility_to | 1.70326398 |
52 | MP0001542_abnormal_bone_strength | 1.69040839 |
53 | MP0005501_abnormal_skin_physiology | 1.69030760 |
54 | MP0004264_abnormal_extraembryonic_tissu | 1.68488738 |
55 | MP0002166_altered_tumor_susceptibility | 1.66474998 |
56 | MP0002060_abnormal_skin_morphology | 1.63572069 |
57 | MP0006276_abnormal_autonomic_nervous | 1.59508294 |
58 | MP0005165_increased_susceptibility_to | 1.57968919 |
59 | MP0002064_seizures | 1.57316531 |
60 | MP0005464_abnormal_platelet_physiology | 1.56650912 |
61 | MP0002398_abnormal_bone_marrow | 1.56297357 |
62 | MP0001501_abnormal_sleep_pattern | 1.52720718 |
63 | MP0001853_heart_inflammation | 1.51594481 |
64 | MP0002822_catalepsy | 1.50194984 |
65 | MP0010155_abnormal_intestine_physiology | 1.49643043 |
66 | MP0001529_abnormal_vocalization | 1.49414543 |
67 | MP0002006_tumorigenesis | 1.48537881 |
68 | MP0002876_abnormal_thyroid_physiology | 1.46991105 |
69 | MP0000716_abnormal_immune_system | 1.46927533 |
70 | MP0001666_abnormal_nutrient_absorption | 1.46874117 |
71 | MP0009046_muscle_twitch | 1.44896781 |
72 | MP0001970_abnormal_pain_threshold | 1.44661064 |
73 | MP0010352_gastrointestinal_tract_polyps | 1.44334096 |
74 | MP0002396_abnormal_hematopoietic_system | 1.43762817 |
75 | MP0005174_abnormal_tail_pigmentation | 1.41995018 |
76 | MP0002572_abnormal_emotion/affect_behav | 1.40798452 |
77 | MP0005058_abnormal_lysosome_morphology | 1.40736944 |
78 | MP0002405_respiratory_system_inflammati | 1.39808775 |
79 | MP0003705_abnormal_hypodermis_morpholog | 1.39590337 |
80 | MP0009333_abnormal_splenocyte_physiolog | 1.38476181 |
81 | MP0009697_abnormal_copulation | 1.36837970 |
82 | MP0002063_abnormal_learning/memory/cond | 1.34508506 |
83 | MP0002733_abnormal_thermal_nociception | 1.33318045 |
84 | MP0001216_abnormal_epidermal_layer | 1.33285269 |
85 | MP0005085_abnormal_gallbladder_physiolo | 1.33257515 |
86 | MP0001881_abnormal_mammary_gland | 1.32977782 |
87 | MP0005310_abnormal_salivary_gland | 1.32854770 |
88 | MP0005275_abnormal_skin_tensile | 1.30464219 |
89 | MP0001243_abnormal_dermal_layer | 1.28135624 |
90 | MP0003300_gastrointestinal_ulcer | 1.27627322 |
91 | MP0000858_altered_metastatic_potential | 1.25459325 |
92 | MP0008872_abnormal_physiological_respon | 1.24647176 |
93 | MP0003252_abnormal_bile_duct | 1.24399113 |
94 | MP0005164_abnormal_response_to | 1.24062878 |
95 | MP0001845_abnormal_inflammatory_respons | 1.23861388 |
96 | MP0000689_abnormal_spleen_morphology | 1.23762107 |
97 | MP0002722_abnormal_immune_system | 1.23481701 |
98 | MP0002272_abnormal_nervous_system | 1.22854214 |
99 | MP0001545_abnormal_hematopoietic_system | 1.22535539 |
100 | MP0005397_hematopoietic_system_phenotyp | 1.22535539 |
101 | MP0005084_abnormal_gallbladder_morpholo | 1.21864094 |
102 | MP0002734_abnormal_mechanical_nocicepti | 1.21690152 |
103 | MP0001663_abnormal_digestive_system | 1.21516782 |
104 | MP0002429_abnormal_blood_cell | 1.21424456 |
105 | MP0003879_abnormal_hair_cell | 1.17215145 |
106 | MP0010386_abnormal_urinary_bladder | 1.16013737 |
107 | MP0005365_abnormal_bile_salt | 1.15085227 |
108 | MP0003786_premature_aging | 1.14418450 |
109 | MP0009643_abnormal_urine_homeostasis | 1.13828379 |
110 | MP0000627_abnormal_mammary_gland | 1.10552245 |
111 | MP0004510_myositis | 1.08184299 |
112 | MP0004808_abnormal_hematopoietic_stem | 1.07268169 |
113 | MP0000465_gastrointestinal_hemorrhage | 1.07064756 |
114 | MP0003303_peritoneal_inflammation | 1.06866566 |
115 | MP0004883_abnormal_blood_vessel | 1.06489018 |
116 | MP0003448_altered_tumor_morphology | 1.05989824 |
117 | MP0000681_abnormal_thyroid_gland | 1.05406034 |
118 | MP0002132_abnormal_respiratory_system | 1.05062529 |
119 | MP0004019_abnormal_vitamin_homeostasis | 1.04921436 |
120 | MP0001727_abnormal_embryo_implantation | 1.03335617 |
121 | MP0006082_CNS_inflammation | 1.03033668 |
122 | MP0008004_abnormal_stomach_pH | 1.02901686 |
123 | MP0010771_integument_phenotype | 1.02008155 |
124 | MP0005167_abnormal_blood-brain_barrier | 1.00595305 |
125 | MP0001664_abnormal_digestion | 0.99246872 |
126 | MP0000343_altered_response_to | 0.99011034 |
127 | MP0006036_abnormal_mitochondrial_physio | 0.98929061 |
128 | MP0010678_abnormal_skin_adnexa | 0.98858088 |
129 | MP0001440_abnormal_grooming_behavior | 0.98629804 |
130 | MP0003453_abnormal_keratinocyte_physiol | 0.97538176 |
131 | MP0004270_analgesia | 0.97519126 |
132 | MP0000015_abnormal_ear_pigmentation | 0.97320021 |
133 | MP0004782_abnormal_surfactant_physiolog | 0.97231738 |
134 | MP0001756_abnormal_urination | 0.96923799 |
135 | MP0004947_skin_inflammation | 0.95981973 |
136 | MP0003868_abnormal_feces_composition | 0.95839828 |
137 | MP0002067_abnormal_sensory_capabilities | 0.95281483 |
138 | MP0008260_abnormal_autophagy | 0.94930921 |
139 | MP0005409_darkened_coat_color | 0.94703471 |
140 | MP0004147_increased_porphyrin_level | 0.93338348 |
141 | MP0000358_abnormal_cell_content/ | 0.92558636 |
142 | MP0000703_abnormal_thymus_morphology | 0.91961872 |
143 | MP0000490_abnormal_crypts_of | 0.91661261 |
144 | MP0005075_abnormal_melanosome_morpholog | 0.91170551 |
145 | MP0003279_aneurysm | 0.90144850 |
146 | MP0001533_abnormal_skeleton_physiology | 0.89780285 |
147 | MP0004957_abnormal_blastocyst_morpholog | 0.89504410 |
148 | MP0005332_abnormal_amino_acid | 0.88879580 |
149 | MP0000516_abnormal_urinary_system | 0.88712990 |
150 | MP0005367_renal/urinary_system_phenotyp | 0.88712990 |
151 | MP0005257_abnormal_intraocular_pressure | 0.87823323 |
152 | MP0002095_abnormal_skin_pigmentation | 0.87289155 |
153 | MP0005319_abnormal_enzyme/_coenzyme | 0.87277054 |
154 | MP0000013_abnormal_adipose_tissue | 0.86908735 |
155 | MP0001958_emphysema | 0.85901615 |
156 | MP0001984_abnormal_olfaction | 0.85404513 |
157 | MP0002909_abnormal_adrenal_gland | 0.84472285 |
158 | MP0003638_abnormal_response/metabolism_ | 0.83855556 |
159 | MP0005166_decreased_susceptibility_to | 0.82877762 |
160 | MP0008469_abnormal_protein_level | 0.82293708 |
161 | MP0003075_altered_response_to | 0.81495866 |
162 | MP0008569_lethality_at_weaning | 0.80592672 |
163 | MP0000538_abnormal_urinary_bladder | 0.80254425 |
164 | MP0002136_abnormal_kidney_physiology | 0.80188583 |
165 | MP0005636_abnormal_mineral_homeostasis | 0.80042119 |
166 | MP0002098_abnormal_vibrissa_morphology | 0.77007984 |
167 | MP0003091_abnormal_cell_migration | 0.76736892 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Mitochondrial inheritance (HP:0001427) | 4.19820706 |
2 | Acute necrotizing encephalopathy (HP:0006965) | 4.15511969 |
3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.98698204 |
4 | Recurrent abscess formation (HP:0002722) | 3.93584329 |
5 | Hepatocellular necrosis (HP:0001404) | 3.88187931 |
6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.70183706 |
7 | Myositis (HP:0100614) | 3.56885905 |
8 | Progressive macrocephaly (HP:0004481) | 3.53662291 |
9 | IgM deficiency (HP:0002850) | 3.52185085 |
10 | Increased CSF lactate (HP:0002490) | 3.44935067 |
11 | Focal motor seizures (HP:0011153) | 3.33162305 |
12 | Abnormality of placental membranes (HP:0011409) | 3.29123415 |
13 | Amniotic constriction ring (HP:0009775) | 3.29123415 |
14 | Thrombocytosis (HP:0001894) | 3.16275400 |
15 | Eczematoid dermatitis (HP:0000976) | 3.16053684 |
16 | Vascular calcification (HP:0004934) | 3.12477512 |
17 | Recurrent bacterial skin infections (HP:0005406) | 3.10941792 |
18 | Cardiovascular calcification (HP:0011915) | 3.10035498 |
19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.08376858 |
20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.08376858 |
21 | Aplastic anemia (HP:0001915) | 3.05455327 |
22 | Hypothermia (HP:0002045) | 3.03576496 |
23 | Hepatic necrosis (HP:0002605) | 2.99515822 |
24 | Acute encephalopathy (HP:0006846) | 2.97968465 |
25 | Abnormal hair whorl (HP:0010721) | 2.97666602 |
26 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.97386536 |
27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.96126318 |
28 | Obstructive lung disease (HP:0006536) | 2.94389736 |
29 | Chronic obstructive pulmonary disease (HP:0006510) | 2.94389736 |
30 | Premature rupture of membranes (HP:0001788) | 2.90193067 |
31 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.88607130 |
32 | Increased hepatocellular lipid droplets (HP:0006565) | 2.88072170 |
33 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.84338440 |
34 | Abnormal number of erythroid precursors (HP:0012131) | 2.82315998 |
35 | Vertebral compression fractures (HP:0002953) | 2.82062932 |
36 | Optic neuritis (HP:0100653) | 2.76431522 |
37 | Retrobulbar optic neuritis (HP:0100654) | 2.76431522 |
38 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.76013458 |
39 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.71037744 |
40 | Osteolytic defects of the hand bones (HP:0009699) | 2.71037744 |
41 | Petechiae (HP:0000967) | 2.69779659 |
42 | Distal lower limb muscle weakness (HP:0009053) | 2.62057342 |
43 | Atonic seizures (HP:0010819) | 2.57112661 |
44 | Orchitis (HP:0100796) | 2.56370971 |
45 | Micronodular cirrhosis (HP:0001413) | 2.55865310 |
46 | Mediastinal lymphadenopathy (HP:0100721) | 2.55721506 |
47 | Stomatitis (HP:0010280) | 2.55150850 |
48 | IgG deficiency (HP:0004315) | 2.54062628 |
49 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.53978959 |
50 | Exertional dyspnea (HP:0002875) | 2.53902837 |
51 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.53231889 |
52 | Renal Fanconi syndrome (HP:0001994) | 2.53229626 |
53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51013976 |
54 | Hypokinesia (HP:0002375) | 2.49550276 |
55 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49217547 |
56 | Popliteal pterygium (HP:0009756) | 2.49208405 |
57 | Meningitis (HP:0001287) | 2.47871057 |
58 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.47622289 |
59 | Increased IgM level (HP:0003496) | 2.46759874 |
60 | Visual hallucinations (HP:0002367) | 2.44009745 |
61 | Sparse eyelashes (HP:0000653) | 2.42704916 |
62 | Myokymia (HP:0002411) | 2.41095412 |
63 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.40667063 |
64 | Onycholysis (HP:0001806) | 2.38549425 |
65 | Chronic otitis media (HP:0000389) | 2.37873085 |
66 | Lipid accumulation in hepatocytes (HP:0006561) | 2.36846029 |
67 | Interstitial pulmonary disease (HP:0006530) | 2.35661265 |
68 | Recurrent bronchitis (HP:0002837) | 2.35591823 |
69 | Exercise intolerance (HP:0003546) | 2.31799648 |
70 | Type I transferrin isoform profile (HP:0003642) | 2.31477157 |
71 | Abnormality of macrophages (HP:0004311) | 2.28676693 |
72 | Palpitations (HP:0001962) | 2.27303320 |
73 | Reticulocytopenia (HP:0001896) | 2.26965952 |
74 | Rough bone trabeculation (HP:0100670) | 2.26293114 |
75 | J-shaped sella turcica (HP:0002680) | 2.25914963 |
76 | Lactic acidosis (HP:0003128) | 2.25573618 |
77 | Respiratory failure (HP:0002878) | 2.25420136 |
78 | Optic disc pallor (HP:0000543) | 2.22959453 |
79 | Recurrent fungal infections (HP:0002841) | 2.22912210 |
80 | Right ventricular cardiomyopathy (HP:0011663) | 2.21858819 |
81 | Cervical subluxation (HP:0003308) | 2.21613584 |
82 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.21272458 |
83 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.21272458 |
84 | Abnormality of glycolipid metabolism (HP:0010969) | 2.21272458 |
85 | Increased serum lactate (HP:0002151) | 2.17883681 |
86 | 3-Methylglutaconic aciduria (HP:0003535) | 2.16007702 |
87 | Vacuolated lymphocytes (HP:0001922) | 2.14981805 |
88 | Glucose intolerance (HP:0000833) | 2.14884081 |
89 | Cerebral edema (HP:0002181) | 2.13794660 |
90 | Type 2 muscle fiber atrophy (HP:0003554) | 2.13592050 |
91 | Abnormality of the nasal mucosa (HP:0000433) | 2.11690981 |
92 | Abnormality of the umbilical cord (HP:0010881) | 2.10961436 |
93 | Chronic sinusitis (HP:0011109) | 2.10798193 |
94 | Fat malabsorption (HP:0002630) | 2.10604968 |
95 | Conjunctival hamartoma (HP:0100780) | 2.10586024 |
96 | Poor suck (HP:0002033) | 2.10133965 |
97 | Steatorrhea (HP:0002570) | 2.08658808 |
98 | Epileptic encephalopathy (HP:0200134) | 2.07619612 |
99 | Progressive neurologic deterioration (HP:0002344) | 2.05795833 |
100 | Hyperventilation (HP:0002883) | 2.05261317 |
101 | Posterior subcapsular cataract (HP:0007787) | 2.05001254 |
102 | Abnormality of the anterior horn cell (HP:0006802) | 2.03340115 |
103 | Degeneration of anterior horn cells (HP:0002398) | 2.03340115 |
104 | Malnutrition (HP:0004395) | 2.03141844 |
105 | Respiratory difficulties (HP:0002880) | 2.03126477 |
106 | Nasal polyposis (HP:0100582) | 2.03041867 |
107 | Febrile seizures (HP:0002373) | 2.02845913 |
108 | Conjugated hyperbilirubinemia (HP:0002908) | 2.02090497 |
109 | Mitral stenosis (HP:0001718) | 2.01098331 |
110 | Increased muscle lipid content (HP:0009058) | 2.00462174 |
111 | Tetraparesis (HP:0002273) | 2.00302262 |
112 | Autoamputation (HP:0001218) | 1.98710511 |
113 | Vasculitis (HP:0002633) | 1.98372488 |
114 | Panhypogammaglobulinemia (HP:0003139) | 1.98283058 |
115 | Abnormality of proline metabolism (HP:0010907) | 1.97926440 |
116 | Hydroxyprolinuria (HP:0003080) | 1.97926440 |
117 | Vascular tortuosity (HP:0004948) | 1.97541569 |
118 | Spondylolisthesis (HP:0003302) | 1.97373692 |
119 | Keratoconjunctivitis sicca (HP:0001097) | 1.96980098 |
120 | Muscle fiber atrophy (HP:0100295) | 1.96802572 |
121 | Recurrent skin infections (HP:0001581) | 1.96732591 |
122 | Pili torti (HP:0003777) | 1.96627290 |
123 | Aortic dissection (HP:0002647) | 1.96102268 |
124 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.96011146 |
125 | Nail dystrophy (HP:0008404) | 1.95595467 |
126 | B lymphocytopenia (HP:0010976) | 1.95088774 |
127 | Abnormality of B cell number (HP:0010975) | 1.95088774 |
128 | Trismus (HP:0000211) | 1.94668879 |
129 | Abnormality of the prostate (HP:0008775) | 1.94594297 |
130 | Chronic diarrhea (HP:0002028) | 1.93719702 |
131 | Hemoptysis (HP:0002105) | 1.93415915 |
132 | Microglossia (HP:0000171) | 1.89456822 |
133 | Hypergammaglobulinemia (HP:0010702) | 1.89008242 |
134 | Arterial tortuosity (HP:0005116) | 1.88919904 |
135 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.87831463 |
136 | Oral leukoplakia (HP:0002745) | 1.87594393 |
137 | Prolonged bleeding time (HP:0003010) | 1.86874736 |
138 | Abnormal trabecular bone morphology (HP:0100671) | 1.86475045 |
139 | Neuroendocrine neoplasm (HP:0100634) | 1.86120602 |
140 | Alopecia of scalp (HP:0002293) | 1.85947122 |
141 | Generalized aminoaciduria (HP:0002909) | 1.85206375 |
142 | Agammaglobulinemia (HP:0004432) | 1.84347276 |
143 | Polyphagia (HP:0002591) | 1.82989212 |
144 | Pulmonary fibrosis (HP:0002206) | 1.82150540 |
145 | Progressive inability to walk (HP:0002505) | 1.82120299 |
146 | Keratoconjunctivitis (HP:0001096) | 1.81282092 |
147 | Neutropenia (HP:0001875) | 1.81226954 |
148 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81192880 |
149 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81192880 |
150 | Oligomenorrhea (HP:0000876) | 1.81028167 |
151 | Reduced antithrombin III activity (HP:0001976) | 1.80851692 |
152 | Abnormal hair laboratory examination (HP:0003328) | 1.80090115 |
153 | Increased serum pyruvate (HP:0003542) | 1.79690177 |
154 | Pulmonary infiltrates (HP:0002113) | 1.79206270 |
155 | Inability to walk (HP:0002540) | 1.78985925 |
156 | Tongue fasciculations (HP:0001308) | 1.78649315 |
157 | Hypobetalipoproteinemia (HP:0003563) | 1.77494896 |
158 | Lethargy (HP:0001254) | 1.76983512 |
159 | Fasciculations (HP:0002380) | 1.76706602 |
160 | Encephalitis (HP:0002383) | 1.76330551 |
161 | Lymphopenia (HP:0001888) | 1.75452759 |
162 | Esophageal neoplasm (HP:0100751) | 1.74817336 |
163 | Neoplasm of head and neck (HP:0012288) | 1.74817336 |
164 | Abnormality of T cell physiology (HP:0011840) | 1.74255779 |
165 | Abnormality of T cells (HP:0002843) | 1.74145007 |
166 | Orthostatic hypotension (HP:0001278) | 1.73944527 |
167 | Emotional lability (HP:0000712) | 1.73361515 |
168 | Prolonged neonatal jaundice (HP:0006579) | 1.73222144 |
169 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.71641758 |
170 | Protrusio acetabuli (HP:0003179) | 1.71460104 |
171 | Nausea (HP:0002018) | 1.71204111 |
172 | Entropion (HP:0000621) | 1.71102417 |
173 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.69452461 |
174 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.69452461 |
175 | Abnormal protein glycosylation (HP:0012346) | 1.69452461 |
176 | Abnormal glycosylation (HP:0012345) | 1.69452461 |
177 | Axonal loss (HP:0003447) | 1.69062876 |
178 | Single umbilical artery (HP:0001195) | 1.68936815 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA2 | 4.33578482 |
2 | MST1R | 3.57866565 |
3 | CDK19 | 3.26516703 |
4 | SCYL2 | 3.17263462 |
5 | STK16 | 3.07081805 |
6 | CASK | 3.02780444 |
7 | TXK | 2.88626830 |
8 | RIPK4 | 2.73949122 |
9 | MAP4K1 | 2.47911558 |
10 | MST4 | 2.42904543 |
11 | MAP2K7 | 2.40885694 |
12 | SIK3 | 2.37291714 |
13 | PBK | 2.25705651 |
14 | VRK2 | 2.00118128 |
15 | PIM2 | 2.00099445 |
16 | TEC | 1.94462944 |
17 | GRK6 | 1.93304781 |
18 | TSSK6 | 1.87965983 |
19 | ZAP70 | 1.83843362 |
20 | ARAF | 1.81926752 |
21 | CCNB1 | 1.78929110 |
22 | NEK1 | 1.76748820 |
23 | MET | 1.70355430 |
24 | * MAP3K12 | 1.69788074 |
25 | IRAK4 | 1.64914982 |
26 | KDR | 1.64727857 |
27 | KIT | 1.63393982 |
28 | MAP3K3 | 1.63272259 |
29 | TRIM28 | 1.61057189 |
30 | SYK | 1.59854713 |
31 | BLK | 1.55325003 |
32 | FES | 1.53151461 |
33 | GRK5 | 1.51075231 |
34 | CAMKK2 | 1.46747312 |
35 | NME1 | 1.43936486 |
36 | ADRBK2 | 1.42340274 |
37 | ERBB3 | 1.40317868 |
38 | VRK1 | 1.37448352 |
39 | PTK2 | 1.33525475 |
40 | BTK | 1.30737439 |
41 | BMPR2 | 1.26312688 |
42 | TNIK | 1.24783021 |
43 | LMTK2 | 1.22193651 |
44 | MAP2K6 | 1.21683083 |
45 | ABL2 | 1.21340400 |
46 | TRPM7 | 1.20453377 |
47 | NTRK3 | 1.19854588 |
48 | MINK1 | 1.18435027 |
49 | * DAPK1 | 1.18425928 |
50 | IKBKE | 1.18187597 |
51 | MAP3K14 | 1.18022079 |
52 | PDK2 | 1.18006751 |
53 | TESK1 | 1.17147577 |
54 | GRK7 | 1.15386418 |
55 | TESK2 | 1.14617959 |
56 | PLK2 | 1.14226953 |
57 | ERBB4 | 1.11945466 |
58 | * PAK4 | 1.08974740 |
59 | EIF2AK3 | 1.05113114 |
60 | BMPR1B | 1.04651535 |
61 | DAPK2 | 1.03597913 |
62 | FER | 1.03242873 |
63 | MATK | 1.00984499 |
64 | CDK8 | 0.98906570 |
65 | NME2 | 0.98174822 |
66 | TBK1 | 0.98034588 |
67 | MAP3K4 | 0.95844724 |
68 | PIK3CA | 0.94903224 |
69 | TIE1 | 0.94587906 |
70 | STK10 | 0.94374191 |
71 | BCR | 0.94197517 |
72 | ITK | 0.92851286 |
73 | LCK | 0.90635866 |
74 | * ILK | 0.85173280 |
75 | LYN | 0.81346326 |
76 | PRKG2 | 0.80535293 |
77 | TNK2 | 0.80217642 |
78 | LIMK1 | 0.79451063 |
79 | MAP2K4 | 0.78070570 |
80 | EPHA4 | 0.76296807 |
81 | MAP3K13 | 0.76287581 |
82 | MUSK | 0.74845442 |
83 | MAP3K9 | 0.73473218 |
84 | PIK3CG | 0.73053077 |
85 | JAK3 | 0.72135623 |
86 | MAP3K11 | 0.71901722 |
87 | * MYLK | 0.71111383 |
88 | CAMK2B | 0.71066326 |
89 | ERN1 | 0.70552987 |
90 | TGFBR1 | 0.68518164 |
91 | PRKCI | 0.67854878 |
92 | ADRBK1 | 0.67787419 |
93 | PTK2B | 0.66536931 |
94 | CAMK2G | 0.65051691 |
95 | OXSR1 | 0.62307381 |
96 | EPHB1 | 0.62297072 |
97 | PAK1 | 0.61212496 |
98 | MAPK4 | 0.60759474 |
99 | PTK6 | 0.60061634 |
100 | CAMK2D | 0.58948047 |
101 | FLT3 | 0.58805238 |
102 | PRPF4B | 0.58617400 |
103 | MAPKAPK2 | 0.57604500 |
104 | MAP3K2 | 0.57374644 |
105 | CSF1R | 0.56762844 |
106 | MAP2K3 | 0.56140859 |
107 | TYK2 | 0.55853448 |
108 | PRKCD | 0.55529375 |
109 | LRRK2 | 0.55135268 |
110 | TAOK2 | 0.54933267 |
111 | JAK1 | 0.54880438 |
112 | STK39 | 0.53476270 |
113 | BUB1 | 0.53355112 |
114 | RAF1 | 0.53218371 |
115 | STK24 | 0.50760563 |
116 | FGR | 0.50011391 |
117 | YES1 | 0.49947471 |
118 | MAPKAPK5 | 0.49881744 |
119 | TGFBR2 | 0.49001426 |
120 | MAPK13 | 0.48851757 |
121 | EIF2AK2 | 0.48611593 |
122 | STK38L | 0.48546520 |
123 | IKBKB | 0.48117620 |
124 | CAMK2A | 0.47726527 |
125 | CAMK1 | 0.46923168 |
126 | EIF2AK1 | 0.46076937 |
127 | NEK6 | 0.45161131 |
128 | RPS6KA6 | 0.44267849 |
129 | PAK2 | 0.44009928 |
130 | EPHB2 | 0.43840973 |
131 | MAP2K1 | 0.43210808 |
132 | RPS6KB2 | 0.41873007 |
133 | HCK | 0.41862604 |
134 | MAPKAPK3 | 0.41229114 |
135 | RPS6KL1 | 0.40551611 |
136 | RPS6KC1 | 0.40551611 |
137 | ABL1 | 0.39744593 |
138 | IRAK3 | 0.39612050 |
139 | DMPK | 0.39549753 |
140 | SIK2 | 0.39255427 |
141 | CDK5 | 0.39141650 |
142 | PRKCE | 0.38261368 |
143 | TAOK3 | 0.37848809 |
144 | ACVR1B | 0.37678263 |
145 | SRPK1 | 0.36495065 |
146 | RPS6KA2 | 0.35716547 |
147 | FYN | 0.35017553 |
148 | MOS | 0.34888690 |
149 | BRSK2 | 0.33771155 |
150 | PDGFRA | 0.33409309 |
151 | MAP3K8 | 0.33208551 |
152 | * ROCK1 | 0.33097889 |
153 | CLK1 | 0.32970000 |
154 | IGF1R | 0.32650768 |
155 | PKN2 | 0.32648564 |
156 | RPS6KA4 | 0.32609748 |
157 | STK3 | 0.31884298 |
158 | EGFR | 0.29254053 |
159 | CSNK1G3 | 0.28136755 |
160 | BMX | 0.24735819 |
161 | LATS1 | 0.24334768 |
162 | NUAK1 | 0.23073766 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.74540847 |
2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.11512463 |
3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.03465777 |
4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.00698816 |
5 | Proteasome_Homo sapiens_hsa03050 | 2.93400120 |
6 | Ribosome_Homo sapiens_hsa03010 | 2.86665488 |
7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.48424791 |
8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.39243724 |
9 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.24906386 |
10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.03230538 |
11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.02815701 |
12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.98099901 |
13 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.91293754 |
14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.85689304 |
15 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.85670201 |
16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.76485335 |
17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74564468 |
18 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.71652923 |
19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.71564974 |
20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63948439 |
21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.63424932 |
22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.60999174 |
23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.59465725 |
24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.54522312 |
25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.53494452 |
26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.46507722 |
27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.46476700 |
28 | Allograft rejection_Homo sapiens_hsa05330 | 1.43701577 |
29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.41162537 |
30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.39677059 |
31 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.37002750 |
32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.36401296 |
33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.34836556 |
34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.34566449 |
35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32992357 |
36 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.31506522 |
37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.31230140 |
38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30841657 |
39 | Protein export_Homo sapiens_hsa03060 | 1.28796949 |
40 | Galactose metabolism_Homo sapiens_hsa00052 | 1.27649371 |
41 | Phagosome_Homo sapiens_hsa04145 | 1.27566796 |
42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.25640359 |
43 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25491385 |
44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20397877 |
45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.19894890 |
46 | Asthma_Homo sapiens_hsa05310 | 1.18491961 |
47 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17422305 |
48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.13971425 |
49 | Salmonella infection_Homo sapiens_hsa05132 | 1.13840168 |
50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12641988 |
51 | Morphine addiction_Homo sapiens_hsa05032 | 1.11821117 |
52 | Shigellosis_Homo sapiens_hsa05131 | 1.11610899 |
53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11312351 |
54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08580445 |
55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08184317 |
56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08081112 |
57 | RNA polymerase_Homo sapiens_hsa03020 | 1.07094913 |
58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.06769980 |
59 | Pertussis_Homo sapiens_hsa05133 | 1.06282666 |
60 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06094375 |
61 | Long-term potentiation_Homo sapiens_hsa04720 | 1.04081361 |
62 | Mineral absorption_Homo sapiens_hsa04978 | 1.03489223 |
63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01514074 |
64 | Circadian entrainment_Homo sapiens_hsa04713 | 0.99871754 |
65 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.96778509 |
66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.92752744 |
67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.92525402 |
68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92040919 |
69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90535739 |
70 | Tuberculosis_Homo sapiens_hsa05152 | 0.89706196 |
71 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.89263825 |
72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89260156 |
73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88819658 |
74 | Measles_Homo sapiens_hsa05162 | 0.87938326 |
75 | Taste transduction_Homo sapiens_hsa04742 | 0.87400270 |
76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87390951 |
77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87214694 |
78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86889339 |
79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83163146 |
80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82859318 |
81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82674385 |
82 | GABAergic synapse_Homo sapiens_hsa04727 | 0.82503369 |
83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82377279 |
84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80996358 |
85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.79732775 |
86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79574224 |
87 | Salivary secretion_Homo sapiens_hsa04970 | 0.78567056 |
88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.77401063 |
89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76730657 |
90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73321591 |
91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73065078 |
92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72382462 |
93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71795335 |
94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71470665 |
95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70456251 |
96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69297074 |
97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69252405 |
98 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68614856 |
99 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.67331689 |
100 | Legionellosis_Homo sapiens_hsa05134 | 0.67119109 |
101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66171375 |
102 | Renin secretion_Homo sapiens_hsa04924 | 0.63766871 |
103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62166889 |
104 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.60739950 |
105 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.59971921 |
106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.59945936 |
107 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59825654 |
108 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58481898 |
109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58177832 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.57270275 |
111 | Phototransduction_Homo sapiens_hsa04744 | 0.57098556 |
112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.56675579 |
113 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56420853 |
114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54835838 |
115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54553304 |
116 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54022538 |
117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52110935 |
118 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52016893 |
119 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51618127 |
120 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51550187 |
121 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.50975286 |
122 | Long-term depression_Homo sapiens_hsa04730 | 0.50953654 |
123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50478720 |
124 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49911593 |
125 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49720293 |
126 | DNA replication_Homo sapiens_hsa03030 | 0.48619118 |
127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47072026 |
128 | Peroxisome_Homo sapiens_hsa04146 | 0.46315582 |
129 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46190913 |
130 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45710362 |
131 | Influenza A_Homo sapiens_hsa05164 | 0.45566324 |
132 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45498505 |
133 | Purine metabolism_Homo sapiens_hsa00230 | 0.45335911 |
134 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42759620 |
135 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.42720060 |
136 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42500802 |
137 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42093016 |
138 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42006989 |
139 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.40757174 |
140 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40532333 |
141 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39882868 |
142 | * Platelet activation_Homo sapiens_hsa04611 | 0.39838383 |
143 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39310328 |
144 | Hepatitis B_Homo sapiens_hsa05161 | 0.38792371 |
145 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.38266007 |
146 | Spliceosome_Homo sapiens_hsa03040 | 0.37939648 |
147 | Lysosome_Homo sapiens_hsa04142 | 0.37764104 |
148 | Malaria_Homo sapiens_hsa05144 | 0.37513530 |
149 | * Focal adhesion_Homo sapiens_hsa04510 | 0.35908525 |
150 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35795671 |
151 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35788511 |
152 | Cocaine addiction_Homo sapiens_hsa05030 | 0.34549812 |
153 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33677150 |
154 | * Tight junction_Homo sapiens_hsa04530 | 0.33180954 |
155 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30193104 |
156 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28012916 |
157 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.27475371 |
158 | Apoptosis_Homo sapiens_hsa04210 | 0.27033786 |
159 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.25772503 |